Patient Experiences After Risk-Reducing Mastectomy Among Women Carrying BRCA1/2 Pathogenic Variants Without a Diagnosis of Breast Cancer

September 9, 2026 updated by: Francesca Dionigi, Fondazione IRCCS Policlinico San Matteo di Pavia

This is a descriptive, exploratory cross-sectional, single-center national study. The study asks a sample of women carrying pathogenic variants associated with hereditary breast and ovarian cancer who have undergone risk-reducing mastectomy (MRR) and have signed informed consent to complete an interview developed on the REDCap platform and sent to their personal email address. The aim of the study is to investigate patients' experiences of satisfaction and their correlations with variables included in the survey, based on evidence from the scientific literature.

These variables include aspects derived from the literature and clinical practice, such as: motivations for choosing to undergo MRR, type of surgical procedure performed, type of reconstruction, presence of residual sensitivity, possible postoperative complications, and the number of surgical procedures required to achieve the final outcome; stability of the couple relationship, partner support, impact of surgery on sexuality, the key question regarding the decision to undergo MRR (question no. 11), and whether the participant would recommend the same pathway to others.

In addition, the survey includes items derived from the Body Image Scale (Hopwood et al., 2001), translated and validated in Italian (Italian version: Cheli et al., 2016), appropriately adapted to assess the same variable in relation to the MRR procedure (questions no. 2, 4, 6, and 8).

Finally, the last section of the survey includes administration of the 12-Item Short Form Survey (SF-12), a widely used measure of quality of life.

The questionnaires included in the survey will be appropriately indicated.

Study Overview

Status

Recruiting

Detailed Description

Hereditary breast and ovarian cancer syndromes are most commonly associated with pathogenic variants in genes such as BRCA1 and BRCA2, which confer a significantly increased lifetime risk of developing breast and ovarian cancer. Women carrying these variants frequently face complex medical and psychological decisions regarding risk management strategies.

Among the available preventive options, risk-reducing mastectomy (MRR) represents one of the most effective strategies to significantly reduce the risk of breast cancer development. Several studies have demonstrated that prophylactic mastectomy can reduce the risk of breast cancer by more than 90% in mutation carriers. However, the decision to undergo MRR is highly personal and involves multiple dimensions including medical risk perception, psychological factors, family history, body image concerns, and expectations regarding reconstructive outcomes.

In recent years, increasing attention has been devoted not only to the clinical effectiveness of risk-reducing surgery but also to the psychological and quality-of-life outcomes experienced by women undergoing these procedures. Research has shown that while many patients report high levels of satisfaction after surgery, others may experience difficulties related to body image, sexual functioning, emotional adjustment, and expectations regarding surgical results.

The literature suggests that satisfaction after risk-reducing mastectomy is influenced by several factors including surgical technique, type of breast reconstruction, postoperative complications, preservation of breast sensitivity, partner support, and alignment between preoperative expectations and postoperative outcomes. Moreover, the psychological experience of women undergoing preventive surgery differs significantly from that of patients treated for an existing cancer diagnosis.

Despite growing international literature on this topic, data derived from the Italian context remain limited, particularly regarding patient-reported experiences and satisfaction following preventive mastectomy among women carrying hereditary cancer variants.

Understanding the experiences of women who have undergone MRR is crucial for improving counseling processes, enhancing shared decision-making, and optimizing multidisciplinary care for individuals with hereditary cancer risk.

For this reason, the present study aims to investigate the experiences, perceptions, and satisfaction of women carrying hereditary cancer variants who have undergone risk-reducing mastectomy.

Study rationale

Women carrying hereditary pathogenic variants often face a complex and emotionally challenging decision when considering preventive surgery. Although prophylactic mastectomy substantially reduces cancer risk, the intervention has profound implications for body image, sexuality, identity, and interpersonal relationships.

Clinical practice suggests that expectations prior to surgery may differ significantly from postoperative experiences. In particular, issues such as aesthetic outcome, loss or alteration of breast sensitivity, the need for multiple surgical procedures, and psychosocial adjustment can influence long-term satisfaction.

Furthermore, relational aspects such as partner support and stability of the couple relationship may play an important role in shaping the psychological adaptation to preventive surgery.

Exploring these aspects through patient-reported outcomes may provide valuable insights for clinicians involved in the management of hereditary cancer risk. Such knowledge may contribute to improving genetic counseling, surgical decision-making, and long-term psychosocial support for women undergoing preventive procedures.

The present study therefore aims to collect systematic data regarding the experiences of women who have undergone risk-reducing mastectomy, focusing on satisfaction, quality of life, body image perception, and relational aspects.

Study objectives Primary objective

The primary objective of the study is to evaluate patient satisfaction following risk-reducing mastectomy in women carrying hereditary breast and ovarian cancer variants.

Secondary objectives

Secondary objectives include:

investigating the relationship between surgical outcomes and patient satisfaction

exploring body image perception after preventive mastectomy

evaluating the impact of surgery on quality of life

analyzing the influence of partner support and couple relationship stability on postoperative adaptation

assessing the perceived impact of surgery on sexuality

identifying factors associated with higher or lower levels of postoperative satisfaction

exploring whether patients would recommend the procedure to other women facing similar decisions

Study design

This study is designed as a descriptive exploratory cross-sectional observational study conducted at a single national center.

The study will involve women carrying pathogenic hereditary cancer variants who have previously undergone risk-reducing mastectomy and who agree to participate by providing informed consent.

Participants will be invited to complete an online survey designed to collect information regarding their experiences with preventive surgery.

The survey will be developed using the REDCap electronic data capture platform, which allows secure management of research data and facilitates participation through remote completion.

Eligible participants will receive an invitation via email containing a secure link to access the survey.

The questionnaire will collect data regarding clinical, surgical, psychological, and relational aspects associated with the experience of preventive mastectomy.

Study population

The study population consists of women carrying pathogenic variants associated with hereditary breast and ovarian cancer syndromes who have undergone risk-reducing mastectomy.

Participants will be recruited among patients previously followed at the clinical center involved in the study.

Data collection

Data will be collected through a structured online survey consisting of multiple sections designed to explore various aspects of the participants' experiences.

The survey includes questions addressing:

motivations for choosing risk-reducing mastectomy

type of surgical procedure performed

type of breast reconstruction

postoperative complications

number of surgical procedures required to achieve the final result

presence or absence of residual breast sensitivity

perception of aesthetic outcome

satisfaction with the decision to undergo surgery

The survey also explores psychosocial aspects such as:

stability of the couple relationship

perceived partner support

impact of surgery on sexual life

psychological adaptation following surgery

Participants are also asked a key question regarding whether, in retrospect, they would make the same decision again and whether they would recommend the procedure to other women facing a similar situation.

Psychological assessment tools

The survey incorporates items derived from validated instruments used to assess body image and quality of life.

Specifically, selected items from the Body Image Scale, originally developed by Hopwood and colleagues and later translated and validated in Italian, have been adapted to assess body image perception in relation to risk-reducing mastectomy.

These questions evaluate aspects such as:

satisfaction with physical appearance

feelings of femininity

comfort with one's body

perception of physical changes following surgery

In addition, the final section of the survey includes the 12-Item Short Form Survey (SF-12), a widely used instrument designed to measure health-related quality of life across both physical and mental health domains.

The inclusion of validated instruments allows for standardized assessment of psychological outcomes and facilitates comparison with existing research.

Data analysis

The study will primarily employ descriptive statistical analyses to summarize participant characteristics and responses to survey items.

Continuous variables will be described using measures such as means and standard deviations, while categorical variables will be summarized using frequencies and percentages.

Exploratory analyses may be conducted to investigate potential associations between variables such as surgical characteristics, relational factors, and levels of satisfaction.

These analyses aim to identify patterns that may contribute to a better understanding of patient experiences following preventive mastectomy.

Ethical considerations

Participation in the study will be entirely voluntary.

All participants will be required to provide informed consent prior to completing the survey.

Data will be collected anonymously and managed in accordance with applicable data protection regulations.

The use of the REDCap platform ensures secure storage of research data and controlled access for authorized study personnel.

Expected impact

The findings of this study may provide valuable insights into the experiences of women undergoing risk-reducing mastectomy in the context of hereditary cancer risk.

By exploring both clinical and psychosocial aspects of preventive surgery, the study may contribute to improving patient counseling, facilitating shared decision-making, and supporting the development of more patient-centered care pathways.

Understanding patient satisfaction and quality-of-life outcomes is essential for guiding clinicians in providing balanced information to individuals considering preventive surgery.

Furthermore, the results may help identify areas where additional psychosocial support may be beneficial for women undergoing this complex decision-making process.

Study Type

Observational

Enrollment (Estimated)

100

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Pavia
      • Pavia, Pavia, Italy, 27100
        • Recruiting
        • Fondazione IRCCS Policlinico San Matteo di Pavia
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

he study population consists of women carrying pathogenic variants associated with hereditary breast and ovarian cancer syndromes who have undergone risk-reducing mastectomy (MRR).

Participants will be identified among patients previously followed at the clinical center participating in the study and who have provided informed consent to participate.

Eligible participants will be invited to complete an online survey developed on the REDCap platform, which will be sent to their personal email address. The survey is designed to collect information regarding their experiences following preventive mastectomy, including satisfaction with the surgical decision, body image perception, quality of life, and relational and psychosocial aspects related to the surgical experience.

The study therefore focuses on patient-reported outcomes in women who have undergone preventive breast surgery due to hereditary cancer risk.

Description

  • Female patients aged 18 years or older.
  • Carriers of pathogenic variants associated with hereditary breast and ovarian cancer syndromes (e.g., BRCA1, BRCA2, or other clinically relevant variants).
  • Having previously undergone risk-reducing mastectomy (MRR).
  • Being followed or previously evaluated at the clinical center participating in the study.
  • Ability to understand the study information and complete the survey.
  • Provision of written informed consent for participation in the study.
  • Inability to understand or complete the questionnaire.
  • Refusal or inability to provide informed consent.
  • Incomplete or missing responses to the survey preventing adequate evaluation of the study outcomes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient satisfaction following risk-reducing mastectomy (MRR).
Time Frame: Up to December 2026

Primary outcome measure:

Patient satisfaction will be assessed through responses to the survey specifically designed for this study, including the key question evaluating whether participants would choose to undergo the same preventive surgery again and whether they would recommend the procedure to other women with hereditary breast cancer risk.

This outcome reflects the overall subjective evaluation of the surgical decision and postoperative experience.

Secondary outcome measures:

Body image perception

Body image perception will be assessed using selected items adapted from the Body Image Scale (Hopwood et al., 2001), translated and validated in Italian. The adapted questions evaluate changes in body perception, feelings of femininity, and satisfaction with physical appearance following risk-reducing mastectomy.

Health-related quality of life

Quality of life will be evaluated using the 12-Item Short Form Health Surv

Up to December 2026

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 1, 2025

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

December 1, 2026

Study Registration Dates

First Submitted

May 7, 2026

First Submitted That Met QC Criteria

September 9, 2026

First Posted (Actual)

September 16, 2026

Study Record Updates

Last Update Posted (Actual)

September 16, 2026

Last Update Submitted That Met QC Criteria

September 9, 2026

Last Verified

September 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • Experiences of RRM

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe